Why insurance is important for life sciences start-ups
Building a life sciences organisation involves balancing innovation, investment and growth while managing a range of operational risks. Whether you're developing a therapeutic product, medical device, diagnostic technology or digital health solution, unexpected events can have a significant impact on progress.
Insurance can act as a backstop to help protect organisations against financial losses arising from certain risks, while also demonstrating a proactive approach to risk management. This can be particularly important when engaging with investors, regulators, research partners, landlords and customers.
Understanding the risks facing life sciences start-ups
Life sciences companies often face a combination of commercial, operational and regulatory risks.
Intellectual property
Many start-ups are built around valuable intellectual property, including patents, proprietary technologies and research data. Disputes over ownership or alleged infringement can be costly and disruptive, particularly during periods of growth or investment activity.
Cyber security and data protection
Life sciences organisations frequently store commercially sensitive information and research data. Cyber attacks, ransomware incidents and data breaches can result in financial losses, operational disruption and reputational damage.
Directors' and officers' liability
Founders and senior leaders make important decisions regarding investment, recruitment, partnerships and business strategy. This can expose directors and officers to personal legal liability. If their decisions are challenged by investors, regulators, employees or other stakeholders, they may face legal action in their personal capacity.
Research and development risks
Early-stage organisations often invest significant resources into research and development. Damage to tangible assets, project delays or interruptions to critical activities can adversely impact budgets and development timelines.
Contractual obligations
As organisations expand, legal agreements with academic partners, contract research organisations and other scientific collaborators may introduce additional liabilities and insurance requirements. Understanding these obligations early can help avoid unnecessary risk.
What insurance should a life sciences start-up consider?
Insurance requirements will vary depending on the nature of the organisation, but several covers are commonly considered by life sciences start-ups.
Employers' liability insurance
Employers' liability insurance is generally a legal requirement for organisations with employees in the UK. It helps protect organisations against claims from employees who suffer injury or illness in connection with their work.
Public liability insurance
Public liability insurance can help protect the organisation where it's legally liable for third-party injury or damage to third-party property. This may be an important consideration for organisations operating from offices, laboratories or shared facilities.
Directors' and officers' insurance
Directors' and officers' (D&O) insurance helps protect founders and senior management where they face allegations of wrongful acts such as error, omission, breach of duty, misstatement, misleading statement or neglect while managing the organisation. This cover is commonly viewed as a key governance requirement by investors, particularly as companies mature and attract external funding.
Cyber liability insurance
Cyber liability insurance can help organisations respond to cyber-related incidents, including data breaches, ransomware attacks, cyber extortion and associated business interruption costs.
Professional indemnity insurance
Organisations providing consultancy, research services or specialist advice may wish to consider professional indemnity insurance. This can help protect against claims alleging errors, omissions or negligence.
Key person cover
For a research-driven life sciences organisations, this cover is often required by investors for founders, principal scientists and other individuals whose knowledge, relationships or reputation are critical to the organisation. Key person cover can help provide financial support if an individual critical to the organisation becomes unable to continue in their role.
Property and business interruption insurance
Laboratory equipment, specialist technology and research materials can represent a significant financial investment. While you can insure this property for loss or damage, business interruption insurance covers the organisation's resulting financial loss and can play a critical role in your journey to recovery.
Clinical trials insurance
This cover is generally mandatory if your organisation is conducting human clinical trials.
